Researchers discovered peptides that permanently block a key cancer protein once thought untreatable, using a new screening ...

We recently published a list of Top 8 AI News Updates Driving Markets Today. In this article, we are going to take a look at ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Cardiff ...

Oncogenic proteins are essential for the development and spread of tumors, making cancer a significant worldwide health ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Eli Lilly, Adaptimmune, Aurion Biotech, and ImmunityBio had breakthrough medicines and therapies debut in the past year.

Thousands of women whose mothers took a widely prescribed drug in pregnancy face more than double the normal risk of breast cancer. A study of 5,000 women found that those over 40 whose mothers ...

Arvinas lost more than half of its market value Tuesday morning after the Connecticut-based biotechnology company and partner Pfizer disclosed anticipated results from a late-stage clinical trial of a ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...

I write about Asia's richest, fast-growing businesses, and startups. Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi—has agreed to buy U.S.-based immunotherapy ...

The field of cancer treatment has long struggled with the immense costs and time-consuming nature of drug development. Traditional methods often take over a decade and billions of dollars to bring a ...